Table 1 Patient characteristics at the initiation of oxandrolone treatment.
From: Oxandrolone Improves Height Velocity and BMI in Patients with Cystic Fibrosis
Pancreatic | Height | Weight | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Age | Gender | Insufficiency | Tanner | Height z | velocity | BMI z | velocity | FEV1 (% | FEV/FVC | |
Patient | (years) | (M/F) | (Y/N) | Stage | score | (cm/yr) | score | (kg/yr) | predicted) | |
1 | 8.5 | F | Y | 1 |
| 5.8 | 0.82 | 6.6 | 118 | 90 |
2 | 11.9 | F | Y | 1 |
| 5.0 |
|
| 91 | 90 |
3 | 14.5 | M | Y | 4 |
| 7.4 |
| 8.8 | 70 | 78 |
4 | 12.6 | M | Y | 1 |
| 4.6 | 0.13 | 4.2 | 95 | 82 |
5 | 12.0 | M | Y | 1 |
| 3.6 |
| 1.4 | 67 | 78 |
Mean | 11.9 |
| 5.3 |
| 4.18 | 88.2 | 83.6 | |||
SD | 2.2 | 0.63 | 1.4 | 1.04 | 3.65 | 20.8 | 6.1 |
2.39
0.74
1.39
0.1
1.97
1.03
1.32
1.76
1.59
1.64
0.61